Combination therapy with carboplatin and paclitaxel for small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy with carboplatin and paclitaxel for small cell lung cancer

Published:2019-01 Issue:1 Volume:57 Page:34-39
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Mouri Atsuto,Yamaguchi Ou,Miyauchi Sachiko,Shiono Ayako,Utsugi Harue,Nishihara Fuyumi,Murayama Yoshitake,Kagamu Hiroshi,Kobayashi Kunihiko

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference31 articles.

1. Small cell lung cancer: state of the art and future perspectives;Stupp;Lung Cancer,2004

2. Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis;Jiang;Clin Lung Cancer,2007

3. A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer;Jiang;J Thorac Oncol,2010

4. Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: american College of Chest Physicians evidence-based clinical practice guidelines;Jett;Chest,2013

5. Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer;Kasajima;Oncol Lett,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel;Molecular Medicine Reports;2023-09-06

2. Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network;IEEE Journal of Biomedical and Health Informatics;2022-11

3. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis;Scientific Reports;2022-06-08

4. Curcumin sensitizes carboplatin treatment in triple negative breast cancer through reactive oxygen species induced DNA repair pathway;Molecular Biology Reports;2022-01-25

5. Lung cancer;InnovAiT: Education and inspiration for general practice;2021-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3